Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: Toxicity and outcome from a dose escalation pilot study

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 2, 2011, Pages 382-389

  Zilli, Thomas ^a   Jorcano, Sandra ^b   Rouzaud, Michel ^a   Dipasquale, Giovanna ^a   Nouet, Philippe ^a   Toscas, José Ignacio ^b   Casanova, Nathalie ^a   Wang, Hui ^a   Escudé, Lluís ^b   Moll, Meritxell ^b   Linero, Dolors ^b   Weber, Damien C ^a   Miralbell, Raymond ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Institut Oncològic Teknon   (Spain)

Author keywords

Acute and late radiation induced toxicity; Biochemical relapse free survival; Hypofractionation; IMRT; Prostate cancer

Indexed keywords

BIOCHEMICAL RELAPSE-FREE SURVIVAL; HYPOFRACTIONATION; IMRT; PROSTATE CANCERS; RADIATION-INDUCED TOXICITY;

DISEASES; PHYSICAL THERAPY; RADIOTHERAPY;

TOXICITY;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CHRONIC TOXICITY; DISEASE FREE SURVIVAL; FOLLOW UP; GASTROINTESTINAL TOXICITY; HIGH RISK POPULATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMEDIATE RISK POPULATION; LOW RISK POPULATION; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PILOT STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION THERAPY ONCOLOGY GROUP GRADING SYSTEM; RISK; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; UROGENITAL TRACT DISEASE;

AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMUR HEAD; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANS AT RISK; PENIS; PILOT PROJECTS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; SALVAGE THERAPY; TIME FACTORS; URINARY BLADDER;

EID: 80052792782     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.05.057     Document Type: Article

References (42)

1. J.R. Sathya, I.R. Davis, and J.A. Julian Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate J Clin Oncol 23 2005 1192 1199 (Pubitemid 46202276)
2. A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 294 2005 1233 1239 (Pubitemid 41352111)
3. D.P. Dearnaley, M.R. Sydes, and J.D. Graham Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial Lancet Oncol 8 2007 475 487 (Pubitemid 46805903)
4. A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105 (Pubitemid 34787842)
5. O. Cahlon, M.J. Zelefsky, and A. Shippy Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes Int J Radiat Oncol Biol Phys 71 2008 330 337
6. M.J. Zelefsky, Z. Fuks, and M. Hunt High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients Int J Radiat Oncol Biol Phys 53 2002 1111 1116 (Pubitemid 34787844)
7. C. Ares, Y. Popowski, and S. Pampallona Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: A sequential dose-escalation pilot study Int J Radiat Oncol Biol Phys 75 2009 656 663
8. L. Astrom, D. Pedersen, and C. Mercke Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer Radiother Oncol 74 2005 157 161 (Pubitemid 40331872)
9. D.J. Demanes, R.R. Rodriguez, and L. Schour High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results Int J Radiat Oncol Biol Phys 61 2005 1306 1316 (Pubitemid 40470411)
10. R.M. Galalae, G. Kovacs, and J. Schultze Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer Int J Radiat Oncol Biol Phys 52 2002 81 90 (Pubitemid 34044108)
11. P.J. Hoskin, K. Motohashi, and P. Bownes High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: Initial results of a randomised phase three trial Radiother Oncol 84 2007 114 120 (Pubitemid 47284526)
12. T. Martin, S. Roddiger, and R. Kurek 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer Radiother Oncol 71 2004 35 41 (Pubitemid 38452900)
13. D.J. Brenner, and E.J. Hall Fractionation and protraction for radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 43 1999 1095 1101 (Pubitemid 29144800)
14. D.J. Brenner, A.A. Martinez, and G.K. Edmundson Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13 (Pubitemid 34041562)
15. G.M. Duchesne, and L.J. Peters What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy Int J Radiat Oncol Biol Phys 44 1999 747 748 (Pubitemid 29284122)
16. J. Fowler, R. Chappell, and M. Ritter Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50 2001 1021 1031 (Pubitemid 32594841)
17. J.E. Livsey, R.A. Cowan, and J.P. Wylie Hypofractionated conformal radiotherapy in carcinoma of the prostate: Five-year outcome analysis Int J Radiat Oncol Biol Phys 57 2003 1254 1259 (Pubitemid 37443962)
18. H. Lukka, C. Hayter, and J.A. Julian Randomized trial comparing two fractionation schedules for patients with localized prostate cancer J Clin Oncol 23 2005 6132 6138
19. E.E. Yeoh, R.H. Holloway, and R.J. Fraser Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase III randomized trial Int J Radiat Oncol Biol Phys 66 2006 1072 1083 (Pubitemid 44633501)
20. K.M. Haustermans, I. Hofland, and H. Van Poppel Cell kinetic measurements in prostate cancer Int J Radiat Oncol Biol Phys 37 1997 1067 1070 (Pubitemid 27237722)
21. M. Ritter Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer Semin Radiat Oncol 18 2008 249 256
22. S. Arcangeli, L. Strigari, and G. Soete Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: Results from a multicentric prospective trial Int J Radiat Oncol Biol Phys 73 2009 39 45
23. F. Leborgne, and J. Fowler Acute toxicity after hypofractionated conformal radiotherapy for localized prostate cancer: Nonrandomized contemporary comparison with standard fractionation Int J Radiat Oncol Biol Phys 72 2008 770 776
24. W. Dorr, and J.H. Hendry Consequential late effects in normal tissues Radiother Oncol 61 2001 223 231 (Pubitemid 33127227)
25. W.D. Heemsbergen, S.T. Peeters, and P.C. Koper Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: Consequential late damage Int J Radiat Oncol Biol Phys 66 2006 3 10 (Pubitemid 44175664)
26. M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129 (Pubitemid 351296130)
27. M. Roach 3rd, C. Marquez, and H.S. Yuo Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 28 1994 33 37 (Pubitemid 24012852)
28. P. Scardino Update: NCCN prostate cancer Clinical Practice Guidelines J Natl Compr Canc Netw 3 Suppl 1 2005 S29 S33
29. A. Diaz, M. Roach 3rd, and C. Marquez Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 30 1994 323 329 (Pubitemid 24309734)
30. G. Soete, J. Van de Steene, and D. Verellen Initial clinical experience with infrared-reflecting skin markers in the positioning of patients treated by conformal radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 52 2002 694 698 (Pubitemid 34158731)
31. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
32. M. Roach 3rd, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
33. P.A. Kupelian, T.R. Willoughby, and C.A. Reddy Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience Int J Radiat Oncol Biol Phys 68 2007 1424 1430 (Pubitemid 47176809)
34. B.L. Madsen, R.A. Hsi, and H.T. Pham Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results Int J Radiat Oncol Biol Phys 67 2007 1099 1105
35. J.M. Martin, T. Rosewall, and A. Bayley Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma Int J Radiat Oncol Biol Phys 69 2007 1084 1089 (Pubitemid 47625844)
36. G. Soete, S. Arcangeli, and G. De Meerleer Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: Report on acute toxicity Radiother Oncol 80 2006 78 81 (Pubitemid 44205307)
37. H. Tsuji, T. Yanagi, and H. Ishikawa Hypofractionated radiotherapy with carbon ion beams for prostate cancer Int J Radiat Oncol Biol Phys 63 2005 1153 1160 (Pubitemid 41505295)
38. F. Leborgne, and J. Fowler Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: A nonrandomized contemporary comparison Int J Radiat Oncol Biol Phys 74 2009 1441 1446
39. M. Ritter, J.D. Forman, and P.A. Kupelian A phase I/II trial of dose-per-fraction escalation for prostate cancer Int J Radiat Oncol Biol Phys 69 2007 S174
40. A. Pollack, A.L. Hanlon, and E.M. Horwitz Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial Int J Radiat Oncol Biol Phys 64 2006 518 526 (Pubitemid 43083441)
41. D. Kuban, A. Pollack, and E. Huang Hazards of dose escalation in prostate cancer radiotherapy Int J Radiat Oncol Biol Phys 57 2003 1260 1268 (Pubitemid 37443963)
42. D.J. D'Ambrosio, T. Li, and E.M. Horwitz Does treatment duration affect outcome after radiotherapy for prostate cancer? Int J Radiat Oncol Biol Phys 72 2008 1402 1407